General Information of the Compound
Compound ID
CP0474369
Compound Name
2-[4-[6-[(4-methoxyphenyl)methyl]-2-pyridin-2-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]piperazin-1-yl]-N,N-dimethylethanamine
    Show/Hide
Structure
Formula
C28H37N7O
Molecular Weight
487.652
Canonical SMILES
COc1ccc(CN2CCc3nc(nc(N4CCN(CCN(C)C)CC4)c3C2)-c2ccccn2)cc1
    Show/Hide
InChI
InChI=1S/C28H37N7O/c1-32(2)14-15-33-16-18-35(19-17-33)28-24-21-34(20-22-7-9-23(36-3)10-8-22)13-11-25(24)30-27(31-28)26-6-4-5-12-29-26/h4-10,12H,11,13-21H2,1-3H3
    Show/Hide
InChIKey
BJUDUIKISWYCRJ-UHFFFAOYSA-N
Physicochemical Property
logP
2.7891
Rotatable Bonds
8
Heavy Atom Count
36
Polar Areas
60.86
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
8
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127041267
ChEMBL ID
CHEMBL3746584
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 100000 nM
   TI
   LI
   LO
   TS